Literature DB >> 16688747

Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: an autopsy study.

Konstantinos Stamatiou1, A Alevizos, E Agapitos, F Sofras.   

Abstract

OBJECTIVE: The present study investigates the incidence of impalpable carcinoma of the prostate and the pathological findings of impalpable prostate carcinoma (PC) detected in autopsy material. The frequency of pre-carcinomatous and non-carcinomatous lesions as well as their relationship to the impalpable PC, were also examined.
MATERIALS AND METHODS: Data were obtained from 212 autopsy specimens of the prostate gland, of men aged above 30 and under 98 years of age, born and living in Greece, who died (between 8/2002 and 8/2004), of causes other than carcinoma of the prostate.
RESULTS: The age-independent frequency of histological PC in our study's population is 18.8% (ranging from 0% to 56.2% according to different age groups), whereas the age-independent frequency of histological benign prostate hyperplasia is 65.5% (ranging from 27.7% to 90.6%), of atypical adenomatous hyperplasia 15.5% (ranging from 5.5% to 25%), of prostatic intraepithelial neoplasia (PIN) 26.4% (ranging from 5.5% to 47.2%) and of prostate atrophy (PA) 10.3% (ranging from 0% to 43.7%). There was a statistically significant correlation between PIN and PC volume. Most impalpable carcinomas found within necropsy material were characterized by small volume, favorable histological type, and relatively low aggressiveness. The prevalence of PC and pre-carcinomatous lesions in our study population appears to be lower than that of most autopsy studies.
CONCLUSIONS: The frequency of clinical PC in a certain population could be related to the frequency and prevalent model of impalpable carcinoma as well as to the frequency of pre-carcinomatous lesions. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16688747     DOI: 10.1002/pros.20339

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  19 in total

Review 1.  Prostate kallikrein markers in diagnosis, risk stratification and prognosis.

Authors:  David Ulmert; M Frank O'Brien; Anders S Bjartell; Hans Lilja
Journal:  Nat Rev Urol       Date:  2009-07       Impact factor: 14.432

Review 2.  Multiparametric MRI in prostate cancer management.

Authors:  Linda M Johnson; Baris Turkbey; William D Figg; Peter L Choyke
Journal:  Nat Rev Clin Oncol       Date:  2014-05-20       Impact factor: 66.675

Review 3.  Randomized controlled screening trials for prostate cancer using prostate-specific antigen: a tale of contrasts.

Authors:  Kyle O Rove; E David Crawford
Journal:  World J Urol       Date:  2011-11-25       Impact factor: 4.226

4.  Overdiagnosis of prostate cancer.

Authors:  Gurdarshan S Sandhu; Gerald L Andriole
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

5.  Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer.

Authors:  Oleksandr N Kryvenko; Michelle Jankowski; Dhananjay A Chitale; Deliang Tang; Andrew Rundle; Sheri Trudeau; Benjamin A Rybicki
Journal:  Mod Pathol       Date:  2012-03-30       Impact factor: 7.842

Review 6.  Lung cancer screening.

Authors:  Antonio Gutierrez; Robert Suh; Fereidoun Abtin; Scott Genshaft; Kathleen Brown
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

Review 7.  Defining the threshold for significant versus insignificant prostate cancer.

Authors:  Theo H Van der Kwast; Monique J Roobol
Journal:  Nat Rev Urol       Date:  2013-05-28       Impact factor: 14.432

Review 8.  Pathologic basis of focal therapy for early-stage prostate cancer.

Authors:  Vladimir Mouraviev; Janice M Mayes; Thomas J Polascik
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

9.  Does educational printed material manage to change compliance with prostate cancer screening?

Authors:  Konstantinos Stamatiou; Andreas Skolarikos; Ioannis Heretis; Vaios Papadimitriou; Alevizos Alevizos; Georgios Ilias; Vasilissa Karanasiou; Anargiros Mariolis; Frank Sofras
Journal:  World J Urol       Date:  2008-04-18       Impact factor: 4.226

Review 10.  Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.

Authors:  Denise R Aberle; Fereidoun Abtin; Kathleen Brown
Journal:  J Clin Oncol       Date:  2013-02-11       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.